Blocking of PSMA-N064 with a 100 × excess of unlabeled PSMA-617 led to a decrease in PSMA-positive tumor uptake from 12 ± 2 to 1 ± 0.1%ID/g (P < 0.001). Here, FOLH1 is linked to neoplasm.